ResMed Inc.RMDNYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +11.08% | +10.26% | +7.92% | +10.20% | +9.07% |
| Gross Profit Growth | +19.52% | +12.23% | +12.45% | +16.44% | +14.44% |
| EBITDA Growth | +29.28% | +27.00% | +9.41% | +46.91% | +13.68% |
| Operating Income Growth | +34.02% | +51.67% | +13.80% | +19.23% | +15.29% |
| Net Income Growth | +41.90% | +65.05% | +21.48% | +29.93% | +11.94% |
| EPS Growth | +42.28% | +65.49% | +22.06% | +30.15% | +12.26% |
| EPS Diluted Growth | +41.61% | +64.79% | +21.57% | +30.30% | +12.32% |
| Weighted Average Shares Growth | -0.15% | -0.18% | -0.16% | -0.30% | -0.26% |
| Weighted Average Shares Diluted Growth | +0.08% | +0.04% | -0.16% | -0.34% | -0.38% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +13.71% | +13.12% | +43.93% | +22.42% | +40.48% |
| Free Cash Flow Growth | +24.66% | +16.14% | +46.43% | +22.81% | +35.44% |
| Receivables Growth | +17.16% | +25.57% | +20.56% | +13.16% | +18.15% |
| Inventory Growth | -4.20% | -21.92% | +4.00% | +12.83% | +3.03% |
| Asset Growth | +7.15% | +3.42% | +11.04% | +18.95% | +15.04% |
| Book Value per Share Growth | +22.40% | +17.42% | +19.98% | +23.06% | +18.14% |
| Debt Growth | -43.15% | -39.65% | -28.07% | -2.53% | -0.46% |
| R&D Expense Growth | +5.04% | +10.14% | +8.91% | +6.90% | +9.81% |
| SG&A Expenses Growth | +7.23% | +8.76% | +6.69% | +9.47% | +8.46% |